Urine Test to Evaluate Immunotherapy Success Gets $1.8 Million NIH Research Grant | Research Horizons
| Date | 2nd, Apr 2019 |
|---|---|
| Source | Georgia Tech - Organizations and Universities Websites |
DESCRIPTION
Cancer immunotherapy is a hopeful, young treatment that shows surprising successes but also dramatic failures. An emerging activity sensor at Georgia Tech warns clinicians of immunotherapy failures so that they can adjust treatments on time.
Bioengineering and Bioscience Electronics and Nanotechnology